Medical Equipment

NGS-Based RNA-Sequencing Market Insights Report: Opportunities and Drivers 2030

February 9, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

How much is the NGS-Based RNA-Sequencing Market valued at in 2026, and what valuation is forecast for 2030?

The ngs-based rna-sequencing market has seen remarkable growth over the past few years. It is anticipated to increase from $4.2 billion in 2025 to $5.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 25.3%. This historical growth stemmed from factors such as the broadening of genomic research initiatives, the falling costs of sequencing technologies, increased adoption of rna-seq in academic research, the availability of advanced sequencing platforms, and the development of bioinformatics capabilities.

The ngs-based rna-sequencing market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $12.73 billion, demonstrating a compound annual growth rate (CAGR) of 24.7%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the increasing utilization of rna sequencing in clinical diagnostics, growing investments in precision medicine, the broadening scope of pharmaceutical research applications, an escalating need for integrated data analysis solutions, and a heightened emphasis on multi-omics research. Key developments expected within this period involve the increasing uptake of high-throughput rna sequencing platforms, a surging demand for single-cell rna sequencing, the expanding application of cloud-based bioinformatics analysis, the wider integration of transcriptomics in precision medicine, and a stronger emphasis on ensuring data accuracy and scalability.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Drivers Are Influencing The Growth Of The NGS-Based RNA-Sequencing Market?

The expanding pharmaceutical sector is projected to boost the future growth of the NGS-based RNA-sequencing market. This industry encompasses the entire process of finding, developing, and manufacturing pharmaceuticals and medications, undertaken by both public and private organizations. NGS-based RNA-sequencing is employed by the pharmaceutical sector for extensive gene expression analysis, pinpointing possible drug targets, evaluating drug effectiveness, and deciphering disease pathways. This advanced technique enhances drug discovery and development by providing profound insights into molecular functions. As an illustration, data from June 2025 by the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, indicates that spending on prescription drugs increased by 11.4% in 2023, reaching $449.7 billion. This represents an acceleration from the 7.8% growth recorded in 2022. Consequently, the expansion of the pharmaceutical industry is stimulating the growth of the NGS-based RNA-sequencing market.

How Is The NGS-Based RNA-Sequencing Market Organized Into Various Segments?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What Industry Trends Are Transforming The NGS-Based RNA-Sequencing Market?

Major companies operating in the NGS-based RNA-sequencing market are prioritizing the development of innovative products, such as advanced small RNA-seq kits, to streamline workflows and improve the accuracy and efficiency of RNA expression analysis. These advanced small RNA-seq kits are cutting-edge library preparation tools engineered to capture and sequence small RNAs with high precision, assisting researchers in reducing workflow duration, minimizing artifacts like adapter dimers, and achieving more accurate and reproducible expression profiling. For instance, in October 2025, Lexogen, an Austria-based biotechnology company, unveiled the miRVEL Profiling Small RNA-Seq Library Prep Kit, specifically designed to simplify and optimize small RNA research workflows. This groundbreaking kit offers a faster and more dependable workflow, allowing for the preparation of ready-to-sequence libraries in under seven hours with minimal hands-on effort. It integrates advanced adapter blocking technology to prevent adapter dimer formation, ensures consistent results across various input amounts, and includes built-in 8 nt unique dual indices (UDIs) for accurate multiplexing and read assignment. The miRVEL Profiling Kit supports a wide array of applications, including RNA interference studies, host-defense mechanism investigations, and plant or agricultural small RNA research. Additionally, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, delivering an integrated, end-to-end solution for small RNA analysis.

Who Are The Prominent Global Companies Shaping The NGS-Based RNA-Sequencing Market Landscape?

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Is Projected To Lead The NGS-Based RNA-Sequencing Market During The Forecast Period?

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized NGS-Based RNA-Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company

Clinical Next Generation Sequencing Ngs Data Analysis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report

Rna Sequencing Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795